Please wait while the formulary information is being retrieved.
MUCINEX FREEFROM SEV CONG-COUG (guaifenesin/dextromethorphan HBr/phenylephrine)
- cold symptoms
- a stuffy and runny nose
- cough
- runny nose
- stuffy nose
- Severe Cough-congestion Oral Liquid
- Mucus Relief Congestion-cough Oral Liquid
- Mucinex Freefrom Severe Congestion-cough Oral Liquid
- Mucinex Fast-max Congestion-cough Oral Liquid
- Children's Mucinex Multi-symptom Oral Liquid
- Child's Mucus Relief M-s Cold Oral Liquid
- Child Mucinex Cough-congest Oral Liquid
2.5 mg-5 mg-100 mg/5 mL oral liquid
- Dosage information is not available
2.5 mg-5 mg-100 mg/5 mL oral liquid
- Dosage information is not available
Mucus Relief Congestion-Cough 2.5 mg-5 mg-100 mg/5 mL oral liquid
- Dosage information is not available
Mucinex Freefrom Sev Congest-Cough 2.5 mg-5 mg-100 mg/5 mL oral liquid
- Dosage information is not available
Mucinex Fast-Max Congestion-Cough 2.5 mg-5 mg-100 mg/5 mL oral liquid
- Dosage information is not available
Multi-Symptom 2.5 mg-5 mg-100 mg/5 mL oral liquid
- Dosage information is not available
tom 2.5 mg-5 mg-100 mg/5 mL oral liquid
- Dosage information is not available
2.5 mg-5 mg-100 mg/5 mL oral liquid
- Dosage information is not available
2.5 mg-5 mg-100 mg/5 mL oral liquid
- Dosage information is not available
- Azilect
- Eldepryl
- isocarboxazid
- linezolid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- rasagiline
- selegiline HCl
- tranylcypromine
- Zelapar
- Zyvox
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- methylergonovine
- Migergot
- Migranal
- Parlodel
- sevoflurane
- Sojourn
- Terrell
- Ultane
Severe
Moderate
- methyldopa
- methyldopa-hydrochlorothiazide
- methyldopate
- reserpine
- Severe uncontrolled hypertension
Contraindicated
- Benign prostatic hyperplasia
- Coronary artery disease
- Hypertension
- Hyperthyroidism
- Systemic mastocytosis
Severe
Moderate
- Chronic heart failure
- No disease contraindications
MUCINEX FREEFROM SEV CONG-COUG (guaifenesin/dextromethorphan HBr/phenylephrine)
- cold symptoms
- a stuffy and runny nose
- cough
- runny nose
- stuffy nose
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Cardiac arrhythmia
- Dizziness
- Headache disorder
- Hyperhidrosis
- Insomnia
- Nervousness
- Pallor
- Tachycardia
- Tremor
- Vomiting
Less Severe
- Abdominal pain with cramps
- Anticholinergic toxicity
- Dizziness
- Drowsy
- Gastrointestinal irritation
- Nausea
- Vomiting
Contraindicated
Dextromethorphan (OTC, Select)
Do not use in pediatrics <6 years of age unless clinician consultation.
Risk of CNS excitation. Do not use age <6 years without clinician consult.
- 1 Day – 6 Years
- 1 Do not use in pediatrics <6 years of age unless clinician consultation.
Phenylephrine (oral)
Do not use in pediatrics <6 years of age unless clinician consultation.
Risk of CNS excitation. Do not use age <6 years without clinician consult.
- 1 Day – 6 Years
- 1 Risk of CNS excitation. Do not use age <6 years without clinician consult.
Severe Precaution
Guaifenesin (Liquid)
No established efficacy for cough and cold products age < 2 years. Do not use unless directed by clinician consultation.
- 1 Day – 2 Years
- No established efficacy for cough and cold products age < 2 years. Do not use unless directed by clinician consultation.
Management or Monitoring Precaution
None
Dextromethorphan
- Severity Level:
2
- Additional Notes: Available human data show no increased risk for major birth defects
Guaifenesin
- Severity Level:
2
- Additional Notes: Available human data show no increased risk for major birth defects
Phenylephrine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Dextromethorphan
Insufficient data available; molecular wt low enough for possible excretion
Insufficient human data available
Oral bioavailability low; infant exposure may be minimal
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; molecular wt low enough for possible excretion |
Guaifenesin
Insufficient data available; molecular wt low enough for possible excretion
Insufficient human data available
Oral bioavailability low; infant exposure may be minimal
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
Phenylephrine
Insufficient data available; molecular wt low enough for possible excretion
Insufficient human data available
Oral bioavailability low; infant exposure may be minimal
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Oral bioavailability low; infant exposure may be minimal |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool